Responsible for genetically modified organisms (GMOs) and the pesticides that are sprayed on them, Monsanto is on the tips of everyone’s tongues lately. Health conscious individuals are doing everything they can to boycott this company and support others instead, even if that means opting for much pricier organic produce.
There are a number of reasons for their concern, including the fact that no long-term studies have been done to show the potential health effects of consuming genetically modified foods or the high levels of pesticides that came with them. The mere fact that this company is responsible for some of the worst chemicals ever created, including Agent Orange, DDT, asbestos, and aspartame, also contributes to this widespread mistrust.
Last September, Bayer, the largest pharmaceutical company in the world, made a deal to buy out Monsanto for $66 billion, even though Monsanto was voted “the most evil company in the world” back in 2013. Unfortunately, this buyout only strengthened Monsanto’s lobbying power.
This corporate giant has now set its sights on another product, one that has garnered increasing attention lately as laws relax and medicinal uses become better understood: cannabis. Despite claiming otherwise, evidence suggests Monsanto may already have ties to cannabis production, a worrisome connection for anyone who uses cannabis medically or even enjoys an occasional puff.
How Is This Connection Made?
Monsanto and Miracle-Gro already have a business partnership. Hawthorne is a front for Miracle-Gro and has already purchased three of the largest cannabis producers in the business, Botanicare, Gavita, and General Hydroponics. A number of other companies have already received buy-out offers, but have refused.
Read the Complete Editorial